We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-11.66%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$42.4B
AUM Growth
-$8.66B
(-17%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
36.25%
Holding
1,002
New
111
Increased
264
Reduced
418
Closed
167
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$786M |
| 2 |
Corning
GLW
|
+$63.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$46M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$33M |
| 5 |
Parker-Hannifin
PH
|
+$28.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$120M |
| 2 |
Amazon
AMZN
|
+$93.1M |
| 3 |
Bank of America Series L
BAC.PRL
|
+$87.3M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$67.8M |
| 5 |
Autodesk
ADSK
|
+$66.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.66% |
| 2 | Consumer Discretionary | 17.39% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 11.57% |
| 5 | Communication Services | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioMarin Pharmaceuticals
BMRN
$12.3B
| $72.1M | 0.17% |
847,201
-72,684
| -8% | -$6.91M |
|
52
Accenture
ACN
$108B
| $71.9M | 0.17% |
510,084
+62,977
| +14% | +$9.96M |
|
53
Mettler-Toledo International
MTD
$28.6B
| $70.3M | 0.17% |
124,316
-145
| -0.1% | -$84.2K |
|
54
Howmet Aerospace
HWM
$113B
| $69.3M | 0.16% |
5,359,510
-77,869
| -1% | -$1.22M |
|
55
S&P Global
SPGI
$120B
| $62.8M | 0.15% |
369,337
-33,984
| -8% | -$6.09M |
|
56
McCormick & Company Non-Voting
MKC
$14.2B
| $58.3M | 0.14% |
836,726
-401,530
| -32% | -$28.8M |
|
57
Ingevity
NGVT
$2.68B
| $58M | 0.14% |
692,609
-86,894
| -11% | -$7.87M |
|
58
AMN Healthcare
AMN
$1.4B
| $55.8M | 0.13% |
985,383
+18,751
| +2% | +$1.05M |
|
59
LyondellBasell Industries
LYB
$19.2B
| $52.7M | 0.12% |
634,003
+31,772
| +5% | +$2.91M |
|
60
Euronet Worldwide
EEFT
$2.7B
| $52.7M | 0.12% |
514,964
-26,573
| -5% | -$2.94M |
|
61
Tyler Technologies
TYL
$12.8B
| $52.3M | 0.12% |
281,694
+84,925
| +43% | +$16.8M |
|
62
Planet Fitness
PLNT
$3.96B
| $52M | 0.12% |
970,484
+70,551
| +8% | +$3.62M |
|
63
Grand Canyon Education
LOPE
$3.98B
| $48.7M | 0.12% |
506,955
+33,930
| +7% | +$3.94M |
|
64
Goldman Sachs
GS
$303B
| $48M | 0.11% |
287,511
-73,768
| -20% | -$14.9M |
|
|
WMGI
65
DELISTED
Wright Medical Group Inc
WMGI
| $46.9M | 0.11% |
1,721,501
+291,460
| +20% | +$8.06M |
|
66
RBC Bearings
RBC
$18B
| $45.8M | 0.11% |
349,367
-15,047
| -4% | -$2.19M |
|
67
Guidewire Software
GWRE
$14.2B
| $42.4M | 0.1% |
528,776
+25,584
| +5% | +$2.23M |
|
68
Generac Holdings
GNRC
$12.5B
| $42M | 0.1% |
845,103
+71,821
| +9% | +$3.85M |
|
|
MDSO
69
DELISTED
Medidata Solutions, Inc.
MDSO
| $42M | 0.1% |
622,340
+38,124
| +7% | +$2.69M |
|
70
WEX
WEX
$6.31B
| $40.7M | 0.1% |
290,245
+4,524
| +2% | +$745K |
|
71
Columbia Sportswear
COLM
$2.93B
| $40.6M | 0.1% |
483,099
+30,309
| +7% | +$2.69M |
|
72
Insulet
PODD
$9.79B
| $40.1M | 0.09% |
505,089
+131,226
| +35% | +$11.1M |
|
73
Pool Corp
POOL
$7.5B
| $39.9M | 0.09% |
268,095
+62,315
| +30% | +$9.33M |
|
74
HubSpot
HUBS
$10.5B
| $39.3M | 0.09% |
312,254
+23,274
| +8% | +$3.05M |
|
|
OPLN
75
Openlane
OPLN
$4.54B
| $38.9M | 0.09% |
2,155,780
+236,024
| +12% | +$4.89M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2018 Portfolio in Review
As of Q4 2018, Loomis, Sayles & Company held 1,002 positions worth $42.4B, down 17% from $51B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Loomis, Sayles & Company's Q4 2018 filing shows 111 new, 264 increased, 418 reduced and 167 closed positions. Its largest new stake was Huron Consulting: 383,634 shares worth $19.7M. The largest sale was Oracle, an estimated $120M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q4 2018 buy was Huron Consulting: 383,634 shares worth $19.7M.
- Loomis, Sayles & Company added most to AT&T in Q4 2018, an estimated $786M increase.
- Loomis, Sayles & Company's biggest Q4 2018 reduction was Oracle, cutting an estimated $120M.
- Loomis, Sayles & Company fully exited HealthEquity in Q4 2018, selling an estimated $52.5M.
- Loomis, Sayles & Company's ten largest holdings make up 36% of its $42.4B portfolio in Q4 2018.
- Loomis, Sayles & Company opened 111 new positions and closed 167 in Q4 2018.
- Loomis, Sayles & Company's portfolio value fell 17% quarter-over-quarter to $42.4B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2018, filed 14 Feb 2019.